NCT00458263View on ClinicalTrials.gov

Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Idiopathic Short Stature
Interventions
DRUG

Somatotropin growth hormone recombinant human

daily Sub Cutaneous injections

Trial Locations (1)

49202

schneider children medical center of Israel, Petah Tikva

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Rabin Medical Center

OTHER

NCT00458263 - Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature | Biotech Hunter | Biotech Hunter